Publication Month: Nov 2020 | Report Code: TIPRE00015873 | No. of Pages: 200 | Category: Medical Device | Status: Published
Biofilms are composed of mixed strains of fungi, bacteria, yeasts, algae, and other microbes. A biofilm develops on the wound surface when certain types of bacteria or fungi adhere to the wound surface and form a matrix over it. Viscous and shiny substances with unpleasant smell are secreted. The rising diabetes cases, increasing incidence of skin injuries due to burns and ulcers wounds, and growing number of surgical procedures across the world fuel the biofilms treatment market growth. Moreover, the rising number of innovations in wound care products is expected to drive market growth during the forecast period. However, the high cost associated with wound care management hinders the growth of the biofilms treatment market.
Rising risks associated with diabetes such as diabetic foot ulcers and pressure sores accelerate demand for advanced bioactive wound care management products. In addition, the prevalence of noncommunicable diseases is increasing due to factors such as antimicrobial resistance, unhealthy lifestyles, alcohol consumption, and smoking. As per the International Diabetes Federation, in 2019, ~463 million adults were affected by diabetes, and the number of adult patients suffering from diabetes is expected to reach 700 million by 2045. As per the International Diabetes Federation, diabetes patients are 15–40 times more likely to require lower-leg amputation. Approximately 85% of amputations are carried out due to the development of a neuropathic foot ulcer.
Based on product, the biofilms treatment market is segmented into debridement equipment, gauzes and dressings, grafts and matrices, and other products. The gauzes and dressings segment held the largest share of the market in 2019. The same segment is anticipated to register the highest CAGR in the market during the forecast period. Many companies are developing advanced dressings to prevent biofilms. For instance, ConvaTec Inc. has developed Hydrofiber Technology, where the soft absorbent dressing material forms a gel when it comes in contact with wound fluid. The technology reduces the dead space where bacteria can grow, and it also provides rapid and sustained antimicrobial activity.
Gauzes are available in woven and nonwoven forms, which have high absorbency and can be applied on both infected and noninfected wounds.
Based on wound type, the biofilms treatment market is segmented into traumatic and surgical wounds, diabetic foot ulcers, pressure ulcers, venous leg ulcers, and other wounds. The traumatic and surgical wounds segment held the largest share of the market in 2019. The same segment is anticipated to register the highest CAGR in the market during the forecast period. The most common traumatic wounds are open fractures, avulsions, and penetrating wounds. According to data published by Centers of Disease Control and Prevention (CDC) in 2019, ~800,000 patients get hospitalized in the US for hip injuries each year. Furthermore, ~300,000 adult patients get hospitalized due to hip fractures. As per the HCUP Statistical Brief, ~22 million visits—of the total annual visits—were reported in the emergency department for the treatments of trauma and accident injury in the US. The growing number of road accidents and sports injuries favors the market growth for traumatic and surgical wounds segment.
Based on end user, the biofilms treatment market is segmented into hospitals, home care settings, and other end users. The hospitals segment held the largest share of the market in 2019. Also, the same segment is estimated to register the highest CAGR in the market during the forecast period. The growth of the market for this segment is attributed to the increasing incidence of burn injuries across the world, especially in low-income countries. Hospitals are the primary healthcare centers approached by a patient seeking first aid and treatment for injuries. In general, patients prefer to visit clinics and hospitals than other healthcare centers. These centers offer various services and good quality treatment, with quick availability of the required equipment. Moreover, the fees for the treatments are reimbursed.
|Market Size Value in||US$ 1,590.31 Million in 2019|
|Market Size Value by||US$ 2,825.80 Million by 2027|
|Growth rate||CAGR of 7.5% from 2020-2027|
|No. of Pages||200|
|No. of Tables||72|
|No. of Charts & Figures||70|
|Historical data available||Yes|
|Segments covered||Product , Wound Type , and End User|
|Regional scope||North America, Europe, Asia Pacific, Middle East & Africa, South & Central America|
|Country scope||US, Canada, Mexico, UK, Germany, Spain, Italy, France, India, China, Japan, South Korea, Australia, UAE, Saudi Arabia, South Africa, Brazil, Argentina|
|Report coverage||Revenue forecast, company ranking, competitive landscape, growth factors, and trends|
|Free Sample Copy Available|
Various companies operating in the biofilms treatment market perform strategies such as product launches, mergers and acquisitions, collaborations, product innovations, and product portfolio expansions to expand their footprint worldwide, maintain the brand name, and meet the growing demand from end users.
The List of Companies - Biofilms Treatment Market